Gastrointestinal Stromal Tumors
📧 Sign up to get email alerts when something new happens for Gastrointestinal Stromal Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors [Phase 3]
Open-label Phase 3 trial of Glivec (imatinib) for unresectable or metastatic malignant gastrointestinal stromal tumors has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of dovitinib in patients with gastrointestinal stromal tumors refractory and/or in…
-
CLINICAL_TRIALS withdrawal · 2015-08-04Clinical Trial Update: Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors [Phase 1]
A Phase 1 trial evaluating dovitinib in combination with imatinib for gastrointestinal stromal tumors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT [Phase 3]
Phase 3 clinical trial update on rechallenge of Imatinib in gastrointestinal stromal tumors after prior treatment failures; study completed …
-
CLINICAL_TRIALS trial_result · 2015-07-27Clinical Trial Update: Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation [Phase 2]
Phase 2 trial updating adjuvant imatinib in high-risk gastrointestinal stromal tumor (GIST) with C-kit mutation; completed with results post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib
This clinical trial update describes using whole-body diffusion-weighted imaging to predict early response to regorafenib in patients with a…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy
A clinical trial evaluating regorafenib in patients with gastrointestinal stromal tumors that progressed after standard therapy is no longer…
-
CLINICAL_TRIALS research · 2014-05-26Clinical Trial Update: Prospective Database of Gastrointestinal Stromal Cell Tumors (GISTs)
This update reports the completion of a prospective database for gastrointestinal stromal tumors (GISTs) sponsored by Washington University …
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg [Phase 3]
A Phase 3 trial evaluating high-dose nilotinib with high-dose imatinib in Gastrointestinal Stromal Tumors refractive to imatinib, which was …
-
CLINICAL_TRIALS trial_result · 2014-03-03Clinical Trial Update: Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST): TKI258 [Phase 2]
Phase 2 trial of Dovitinib (TKI258) in imatinib/sunitinib-resistant gastrointestinal stromal tumors has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST) [Phase 3]
Phase 3 trial updating regorafenib as a third-line or beyond therapy for Gastrointestinal Stromal Tumors (GIST) has completed with results p…
-
CLINICAL_TRIALS trial_result · 2013-08-16Clinical Trial Update: Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients [Phase 3]
Phase 3 study comparing dose escalation versus no dose escalation of imatinib in metastatic gastrointestinal stromal tumors was terminated; …
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib [Phase 3]
A Phase 3 study evaluating the Hsp90 inhibitor IPI-504 for gastrointestinal stromal tumors after failure of imatinib and sunitinib has been …
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST) [Phase 4]
Post-marketing Phase 4 study update evaluating postoperative adjuvant therapy with imatinib mesylate in patients with gastrointestinal strom…
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study) [Phase 2]
A completed Phase II extension study evaluating imatinib mesylate in patients with malignant gastrointestinal stromal tumors.
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Sorafenib for Imatinib/Sunitinib-failed GIST [Phase 2]
A Phase 2 trial evaluating sorafenib in patients with gastrointestinal stromal tumors that progressed after imatinib and sunitinib has compl…
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Nilotinib in Advanced Gastrointestinal Stromal Tumors (GIST) [Phase 2]
A Phase 2 trial of nilotinib in patients with advanced gastrointestinal stromal tumors was terminated; results were posted in August 2011.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib [Phase 3]
This Phase 3 trial evaluates the efficacy and safety of nilotinib (AMN107) in patients with gastrointestinal stromal tumors who have failed …
-
CLINICAL_TRIALS trial_result · 2011-01-06Clinical Trial Update: Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS) [Phase 1]
Phase 1 safety study of IPI-504 in patients with gastrointestinal stromal tumors and soft tissue sarcomas has completed.
-
CLINICAL_TRIALS research · 2010-08-04Clinical Trial Update: Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting
A completed study analyzing how gastrointestinal stromal tumors are treated in community oncology settings, providing observational data on …